Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    G1 Therapeutics Inc.

    NASDAQ: GTHX · Real-Time Price · USD
    7.16
    0.01 (0.14%)
    At close: Sep 17, 2024, 9:56 PM

    G1 Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -47.97M -147.56M -148.35M
    Depreciation & Amortization
    		 513K 530K 469K
    Stock-Based Compensation
    		 14.51M 20.59M 22.32M
    Other Working Capital
    		 -3.98M 8.39M 759K
    Other Non-Cash Items
    		 -1.42M 3.13M 1.7M
    Deferred Income Tax
    		 1.23M n/a 590K
    Change in Working Capital
    		 -5.2M -5.31M -8.84M
    Operating Cash Flow
    		 -38.34M -128.62M -132.11M
    Capital Expenditures
    		 n/a -506K n/a
    Cash Acquisitions
    		 n/a 50.02M n/a
    Purchase of Investments
    		 -124.69M -65.02M n/a
    Sales Maturities Of Investments
    		 127.5M 15M n/a
    Other Investing Acitivies
    		 2.81M -50.02M n/a
    Investing Cash Flow
    		 2.81M -50.53M n/a
    Debt Repayment
    		 -26.69M n/a 55M
    Common Stock Repurchased
    		 n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a
    Other Financial Acitivies
    		 -224K 112K 4.43M
    Financial Cash Flow
    		 -26.91M 52.49M 145.86M
    Net Cash Flow
    		 -62.38M -126.65M 13.76M
    Free Cash Flow
    		 -38.34M -129.13M -132.11M

    Add to Watchlist